# US 2019/0167719 A1 · Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167719 A1
- Document ID: US20190167719A1
- Status: Published application
- Kind: A1
- Application number: 16/273,461
- Filed: 2019-02-12
- Published: 2019-06-06
- Earliest claimed: 2016-04-28
- Assignees: Alkahest, Inc.
- Applicants: Alkahest, Inc.
- Inventors: Steven P. Braithwaite; S. Sakura Minami; Joseph McCracken
- Web page: https://patentgrep.com/patent/US20190167719A1

## CPC

- A61K 35/16: Blood plasma; Blood serum (umbilical cord blood A61K35/51)
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.

## Claims

### Claim 1

A method of treating a cancer, the method comprising administering an effective amount of a blood plasma product to a subject diagnosed with the cancer.

### Claim 2 (depends on 1)

The method of claim 1, wherein the blood plasma product is a young plasma.

### Claim 3 (depends on 1)

The method of claim 1, wherein the blood plasma product is a Plasma Fraction.

### Claim 4 (depends on 3)

The method of claim 3, wherein the Plasma Fraction is a Plasma Protein Fraction.

### Claim 5 (depends on 4)

The method of claim 4, wherein the Plasma Protein Fraction is a commercially available Plasma Protein Fraction.

### Claim 6 (depends on 3)

The method of claim 3, wherein the Plasma Fraction is a protein-enriched plasma protein product.

### Claim 7 (depends on 1)

The method of claim 1, wherein the cancer is comprised of a solid tumor.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cancer is a hematopoietic cancer.

### Claim 9 (depends on 1)

The method of claim 1, wherein the cancer is a colorectal cancer.

### Claim 10 (depends on 1)

The method of claim 1, wherein the cancer is a gastric cancer.

### Claim 11 (depends on 1)

The method of claim 1, wherein the cancer is a liver cancer.

### Claim 12 (depends on 1)

The method of claim 1, wherein the cancer is a B lymphocyte Burkitt's lymphoma.

### Claim 13 (depends on 1)

The method of claim 1, wherein the cancer is a renal cancer.

### Claim 14 (depends on 1)

The method of claim 1, wherein the cancer is a thymic cancer.